Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

Saved in:

Bibliographic Details
Published in	Leukemia & lymphoma Vol. 61; no. 12; pp. 2980 - 2984
Main Authors	Furqan, Fateeha, Watson, Grace, Samaniego, Felipe, Fayad, Luis E., Morrison, Michael W., Thompson, Philip A., Steiner, Raphael E., Chi, Linda, Dabaja, Bouthaina, Pinnix, Chelsea C., Neelapu, Sattva S., Nastoupil, Loretta J., Strati, Paolo
Format	Journal Article
Language	English
Published	United States Taylor & Francis 14.10.2020
Subjects	Adenine - analogs & derivatives Central Nervous System Humans Lymphoma, B-Cell, Marginal Zone - diagnosis Lymphoma, B-Cell, Marginal Zone - drug therapy Piperidines Pyrazoles - adverse effects Pyrimidines - adverse effects
Online Access	Get full text

Loading…

More Information
Bibliography:	Authorship Contributions FF collected clinical data and wrote the paper; LJN, FS, LEF, PAT, BD, CCP, SSN and RES provided clinical care to patients and coauthored the paper; GW and MWM collected clinical data and coauthored the paper; RKS reviewed pathological findings and coauthored the paper; LC reviewed neuro-radiological findings and coauthored the paper; PS designed the study, collected and analyzed the data, provided clinical care to patients, and wrote the paper.
ISSN:	1042-8194 1029-2403
DOI:	10.1080/10428194.2020.1791849